Bruker Corp. Aktie
37,36 €
Deine Einschätzung
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 0,54 % | -12,28 % | -8,41 % | -33,36 % | -8,41 % | - | - |
| Healthequity Inc. | -0,72 % | -2,13 % | -11,54 % | -34,91 % | -11,54 % | 26,61 % | 1,47 % |
| Omnicell Inc. | - | -4,23 % | 5,15 % | -5,56 % | 5,15 % | -20,78 % | -58,15 % |
| Myriad Genetics | -1,30 % | -8,10 % | -14,34 % | -62,79 % | -14,34 % | -74,90 % | -80,02 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




